Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 04:00PM ET
325.50
Dollar change
+3.14
Percentage change
0.97
%
Index- P/E- EPS (ttm)-27.33 Insider Own31.60% Shs Outstand22.92M Perf Week-4.41%
Market Cap9.21B Forward P/E28.27 EPS next Y11.51 Insider Trans-0.04% Shs Float19.15M Perf Month-12.72%
Income-778.69M PEG- EPS next Q2.87 Inst Own68.44% Short Float2.74% Perf Quarter0.75%
Sales2.58B P/S3.57 EPS this Y-12.69% Inst Trans-7.85% Short Ratio1.81 Perf Half Y13.41%
Book/sh267.46 P/B1.22 EPS next Y11.93% ROA-6.92% Short Interest0.52M Perf Year4.75%
Cash/sh57.61 P/C5.65 EPS next 5Y12.00% ROE-9.79% 52W Range262.12 - 387.99 Perf YTD0.81%
Dividend Est.- P/FCF37.34 EPS past 5Y- ROI-8.82% 52W High-16.11% Beta0.90
Dividend TTM- Quick Ratio4.52 Sales past 5Y3.42% Gross Margin54.41% 52W Low24.18% ATR (14)11.28
Dividend Ex-Date- Current Ratio6.14 EPS Y/Y TTM-376.51% Oper. Margin13.35% RSI (14)42.03 Volatility3.31% 3.22%
Employees8030 Debt/Eq0.19 Sales Y/Y TTM-5.15% Profit Margin-30.18% Recom1.86 Target Price399.33
Option/ShortYes / Yes LT Debt/Eq0.18 EPS Q/Q541.90% Payout- Rel Volume0.52 Prev Close322.36
Sales Surprise3.43% EPS Surprise73.70% Sales Q/Q2.79% EarningsOct 30 AMC Avg Volume290.31K Price325.50
SMA20-3.69% SMA50-4.56% SMA2002.55% Trades Volume151,252 Change0.97%
Date Action Analyst Rating Change Price Target Change
Oct-01-24Upgrade Citigroup Neutral → Buy $350 → $400
Aug-28-24Initiated Wells Fargo Equal Weight $340
Jun-03-24Resumed Jefferies Hold $315
Apr-03-24Downgrade Citigroup Buy → Neutral $400 → $365
Dec-07-23Initiated UBS Buy $395
Jun-16-23Initiated Wells Fargo Overweight $550
Dec-07-22Initiated RBC Capital Mkts Outperform $565
Aug-25-22Initiated Credit Suisse Outperform $715
Jan-28-22Reiterated Citigroup Buy $915 → $750
Jan-08-20Initiated Wells Fargo Overweight $430
Nov-24-24 08:05PM
Nov-21-24 09:00AM
Oct-31-24 11:52AM
09:00AM
Oct-30-24 04:15PM
05:30PM Loading…
Oct-14-24 05:30PM
Sep-23-24 07:45AM
Sep-22-24 06:00AM
Sep-19-24 04:20PM
Sep-09-24 10:56AM
Sep-06-24 06:43PM
Aug-28-24 05:25PM
Aug-22-24 04:30PM
Aug-20-24 08:30AM
Aug-01-24 04:15PM
04:30PM Loading…
Jul-17-24 04:30PM
Jun-21-24 08:30AM
Jun-14-24 04:35AM
Jun-06-24 11:31AM
May-30-24 09:00AM
May-23-24 04:15PM
May-08-24 01:52PM
12:17PM
09:03AM
May-07-24 05:30PM
04:15PM
May-04-24 12:15AM
May-03-24 12:15PM
May-01-24 09:00AM
Apr-30-24 10:00AM
08:30AM Loading…
Apr-26-24 08:30AM
Apr-18-24 10:03AM
09:00AM
Apr-16-24 10:56AM
Apr-11-24 05:30PM
Apr-10-24 04:15PM
Mar-31-24 04:34PM
Mar-20-24 08:30AM
Mar-12-24 08:27AM
Feb-24-24 03:25PM
Feb-22-24 04:30PM
Feb-15-24 04:15PM
Feb-05-24 11:32AM
Jan-24-24 05:00PM
Jan-02-24 04:15PM
Dec-12-23 12:42PM
Oct-27-23 11:21AM
Oct-26-23 04:15PM
Oct-05-23 08:30AM
Sep-19-23 05:43AM
Aug-28-23 04:15PM
Aug-03-23 04:15PM
Jul-26-23 04:15PM
Jul-20-23 04:30PM
Jul-10-23 04:30PM
09:00AM
Jun-26-23 04:00PM
Jun-21-23 08:00PM
Jun-01-23 08:00AM
May-08-23 08:00AM
May-04-23 04:15PM
Apr-26-23 08:00PM
Apr-12-23 04:11PM
Feb-17-23 09:00AM
Feb-16-23 04:05PM
Feb-08-23 08:00AM
Feb-07-23 09:00AM
Jan-06-23 09:00AM
Jan-04-23 09:00AM
Dec-07-22 02:30PM
07:51AM
Nov-30-22 09:25AM
Nov-20-22 03:48PM
Nov-08-22 01:50PM
Oct-31-22 08:30AM
Oct-28-22 01:01PM
Oct-27-22 05:45PM
04:05PM
Oct-26-22 11:31AM
Oct-18-22 12:01PM
Oct-17-22 08:30AM
Oct-13-22 09:08AM
Oct-12-22 01:10PM
Oct-11-22 04:09PM
07:53AM
Oct-10-22 11:00PM
06:25PM
04:48PM
02:24PM
Oct-03-22 10:00AM
Sep-01-22 10:59AM
10:45AM
Aug-29-22 11:45AM
Aug-25-22 12:20PM
Aug-22-22 12:56PM
Aug-18-22 08:32AM
Aug-15-22 09:09AM
Aug-04-22 03:01PM
Aug-03-22 04:15PM
Jul-29-22 11:28AM
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Last Andrew J.OfficerNov 06 '24Proposed Sale373.643,0001,120,934Nov 06 06:26 PM
EVRAN SEDATEVP, Global Supply ChainOct 20 '24Option Exercise0.001,04401,188Oct 22 04:30 PM
Last Andrew J.OfficerSep 12 '24Proposed Sale321.571,600514,505Sep 12 06:22 PM
Last Andrew J.EVP, Chief Operating OfficerSep 06 '24Option Exercise299.243,000897,72010,559Sep 10 02:05 PM
Last Andrew J.EVP, Chief Operating OfficerSep 06 '24Sale329.943,000989,8157,559Sep 10 02:05 PM
Last Andrew J.OfficerSep 06 '24Proposed Sale329.943,000989,815Sep 06 04:16 PM
Crowley MichaelEVP, GBL Commercial OperationsSep 03 '24Option Exercise0.0055708,454Sep 05 09:36 AM
Crowley MichaelEVP, GBL Commercial OperationsSep 02 '24Option Exercise0.0043408,052Sep 05 09:36 AM
Crowley MichaelEVP, GBL Commercial OperationsSep 01 '24Option Exercise0.001,67607,763Sep 05 09:36 AM
SCHWARTZ NORMAN DChairman, President, and CEOSep 03 '24Option Exercise0.002,3200439,479Sep 04 08:35 PM
SCHWARTZ NORMAN DChairman, President, and CEOSep 02 '24Option Exercise0.001,8050438,124Sep 04 08:35 PM
SCHWARTZ NORMAN DChairman, President, and CEOSep 01 '24Option Exercise0.006,3520436,864Sep 04 08:35 PM
COREY COLLEENEVP, Global Human ResourcesSep 03 '24Option Exercise0.00495018,656Sep 04 08:25 PM
COREY COLLEENEVP, Global Human ResourcesSep 02 '24Option Exercise0.00361018,290Sep 04 08:25 PM
COREY COLLEENEVP, Global Human ResourcesSep 01 '24Option Exercise0.001,100018,020Sep 04 08:25 PM
BARRY JAMESEVP, President, LSGSep 03 '24Option Exercise0.002170848Sep 04 08:24 PM
BARRY JAMESEVP, President, LSGSep 02 '24Option Exercise0.002650726Sep 04 08:24 PM
BARRY JAMESEVP, President, LSGSep 01 '24Option Exercise0.006000525Sep 04 08:24 PM
BARRY JAMESEVP, President, LSGSep 04 '24Sale330.49623205,898147Sep 04 08:24 PM
Last Andrew J.EVP, Chief Operating OfficerSep 02 '24Option Exercise0.0090308,017Sep 04 08:19 PM
Last Andrew J.EVP, Chief Operating OfficerSep 01 '24Option Exercise0.002,75207,435Sep 04 08:19 PM
Allison SchwartzDirectorSep 03 '24Option Exercise0.005601,332Sep 04 08:08 PM
Allison SchwartzDirectorSep 02 '24Option Exercise0.004401,297Sep 04 08:08 PM
Allison SchwartzDirectorSep 01 '24Option Exercise0.0014701,268Sep 04 08:08 PM
BARRY JAMESOfficerSep 04 '24Proposed Sale330.49623205,898Sep 04 06:24 PM
Alles Institute for Medical ReDirectorAug 27 '24Proposed Sale311.34990308,225Aug 27 12:45 PM
Crowley MichaelEVP, GBL Commercial OperationsJun 13 '24Sale281.91369104,0236,573Jun 14 01:42 PM
Last Andrew J.EVP, Chief Operating OfficerApr 29 '24Option Exercise0.001,00006,077Apr 30 05:53 PM
ERNST TIMOTHY SEVP, General Counsel & SecFeb 28 '24Option Exercise326.152,500815,3755,897Feb 29 05:24 PM
ERNST TIMOTHY SEVP, General Counsel & SecFeb 28 '24Sale330.552,500826,3753,397Feb 29 05:24 PM
Crowley MichaelEVP, GBL Commercial OperationsFeb 27 '24Option Exercise215.983,000647,9409,942Feb 28 06:38 PM
Crowley MichaelEVP, GBL Commercial OperationsFeb 27 '24Sale336.003,0001,008,0006,942Feb 28 06:38 PM
WRIGHT DARAEVP, President, CDGDec 16 '23Option Exercise0.0050202,001Dec 19 12:19 PM
WRIGHT DARAEVP, President, CDGDec 12 '23Sale299.161,200358,9921,499Dec 12 07:43 PM